Johnson & Johnson reports mixed OTC results

18 April 2018 - Deborah Wilkes

Archived

Johnson & Johnson's worldwide OTC sales increased by 0.9% on an operational basis in the first quarter of 2018, as sales declined in the US but increased in the rest of the world.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: